<?xml version="1.0" encoding="UTF-8"?><profile href="/about_us/FacultyDirectory/MicrobiologyBiochemistryImmunology/ShaileshSingh/index.php">
   <image><img src="/_resources/MSMimages/FacultyDirectoryImages/MBI/SSingh.jpg" alt="Shailesh Singh, Ph.D."></img></image>
   <name>Shailesh Singh, Ph.D.</name>
   <title>Professor</title>
   <department>Microbiology, Biochemistry &amp; Immunology</department>
   <email>shsingh@msm.edu</email>
   <title2></title2>
   <department2></department2>
   <phone>404-756-5718</phone>
   <location>Hugh Gloster Building</location>
   <education><strong>GRADUATE:</strong><br></br>Banaras Hindu University<br></br><strong>Degree: </strong>Doctor of Philosophy in Cancer Biology<br></br><br></br>Banaras Hindu University<br></br><strong>Degree: </strong>Master of Science in Endocrinology and Reproductive Physiology<br></br><br></br><strong>UNDERGRADUATE:</strong><br></br>Banaras Hindu University<br></br><strong>Degree: </strong>Bachelor of Science in Zoology, Botany and Chemistry</education>
   <research>
      <p>Long-term research interest of my laboratory includes developing comprehensive treatment/prevention
         strategies for prostate, breast and ovarian cancer. These strategies are directed
         to tumor cells and/or immune system using natural and synthetic products as a single
         agent or in combination with conventional therapeutics.<br></br><br></br>Our research approach involves mechanistic studies to define the role of chemokines
         in cancer metastasis (i.e. detachment, motility, adhesion, invasion, survival and
         tumor growth at distant sites) as well as developing strategies to inhibit metastasis
         and enhance chemotherapeutic efficacy. Additionally, we are developing methods to
         overcome tumor induced immune suppression using natural products that treat/prevent
         cancer as a single agent or in combination with traditional therapeutics.<br></br><br></br></p>
      <div style="text-align: center;"><strong><a href="https://www.shsinghlab.com/toolsandcalculators" target="_blank" rel="noopener">View Cancer Biology Research Tools</a></strong></div>
   </research>
   <boardcerts></boardcerts>
   <publications>
      <div class="rprt">
         <div class="rslt">
            <p class="title">Gupta P, Sharma PK, Mir H, Singh R, Singh N, Kloecker GH, Lillard JW Jr, <strong>Singh S. </strong>CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease
               and mediates key steps of metastasis. <span class="jrnl" title="Oncotarget">Oncotarget</span>. 2014 Sep 25. PMID: 25296976 <br></br><br></br>Singh R, Gupta P, Kloecker GH, <strong>Singh S</strong>, Lillard JW Jr. Expression and clinical significance of CXCR5/CXCL13 in human non‑small
               cell lung carcinoma. <span class="jrnl" title="International journal of oncology">Int J Oncol</span>. 2014 Dec;45(6):2232-40. doi: 10.3892/ijo.2014.2688. Epub 2014 Sep 30. PMID: 25271023
               <br></br><br></br>Rai D, Malhotra HS, Garg RK, Goel MM, Malhotra KP, Kumar V, Singh AK, Jain A, Kohli
               N, <strong>Singh SK.</strong> Nerve abscess in primary neuritic leprosy. <span class="jrnl" title="Leprosy review">Lepr Rev</span>. 2013 Jun;84(2):136-40. PMID: 24171239 <br></br><br></br>Singh R, Gupta P, Sharma PK, Ades EW, Hollingshead SK, <strong>Singh S,</strong> Lillard JW. Prediction and characterization of helper T-cell epitopes from pneumococcal
               surface adhesin A. <span class="jrnl" title="Immunology">Immunology</span>. 2014 Apr;141(4):514-30. doi: 10.1111/imm.12194. PMID: 24138116<br></br><br></br>Kumar Goyal N, Goel A, Sankhwar SN, Mandal S, Singhai A, <strong>Singh S. </strong>Cheek metastasis from a bladder tumor: unusual presentation of an aggressive disease. <span class="jrnl" title="Urologia">Urologia</span>. 2013 Sep-Dec;80(4):317-21. doi: 10.5301/urologia.5000022. Epub 2013 Jun 24. PMID: 23813285<br></br><br></br>El-Haibi CP, Sharma P, Singh R, Gupta P, Taub DD, <strong>Singh S,</strong> Lillard JW Jr. Differential G protein subunit expression by prostate cancer cells
               and their interaction with CXCR5. <span class="jrnl" title="Molecular cancer">Mol Cancer</span>. 2013 Jun 18;12:64. doi: 10.1186/1476-4598-12-64. PMID: 23773523<br></br><br></br><br></br>Click <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Shailesh+Singh">here</a> to view additional publications.</p>
         </div>
      </div>
   </publications>
   <awards></awards>
</profile>